Detalles de la búsqueda
1.
Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review.
Value Health;
2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38641057
2.
Building a Platform for Meaningful Patient Partnership to Accelerate "Bench-to-Bedside" Translation of Promising New Therapies.
Healthc Q;
24(SP): 74-79, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467515
3.
Evaluation of a preoperative personalized risk communication tool: a prospective before-and-after study.
Can J Anaesth;
67(12): 1749-1760, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32929659
4.
Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: "It's About Time we Bring Trials to People".
Ther Innov Regul Sci;
2024 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38904884
5.
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived Experience.
Pharmacoeconomics;
40(11): 1119-1130, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36071263
6.
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.
Front Immunol;
13: 1074740, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36601119
7.
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.
Trials;
22(1): 230, 2021 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33766105
8.
Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy.
BMJ Open;
11(8): e046707, 2021 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34385243
9.
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial.
BMJ Open;
11(3): e043929, 2021 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741670
10.
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials.
Res Involv Engagem;
6: 61, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33072399
Resultados
1 -
10
de 10
1
Próxima >
>>